Prevention of latently expressed CYP2C11, CYP3A2, and growth hormone defects in neonatally monosodium glutamate-treated male rats by the N-methyl-D-aspartate receptor antagonist dizocilpine maleate (Q44072200)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Prevention of latently expressed CYP2C11, CYP3A2, and growth hormone defects in neonatally monosodium glutamate-treated male rats by the N-methyl-D-aspartate receptor antagonist dizocilpine maleate |
scientific article |
Statements
1 reference
Prevention of latently expressed CYP2C11, CYP3A2, and growth hormone defects in neonatally monosodium glutamate-treated male rats by the N-methyl-D-aspartate receptor antagonist dizocilpine maleate (English)
1 reference
Antje Kaufhold
1 reference
Prabhat K Nigam
1 reference
Ravindra N Dhir
1 reference
Bernard H Shapiro
1 reference
1 August 2002
1 reference
1 reference
302
1 reference
2
1 reference
490-496
1 reference
Identifiers
1 reference
1 reference